13th July 2020 Overnight Market Wrap

13th July 2020 Overnight Market Wrap

 Key Points

  • U.S. equities posted gains on Friday
  • Currencies quiet; oil prices firmer, gold weaker
  • Gilead: Promising results from Corona Virus vaccine clinical trial

Bias: Risk neutral

Commentary

U.S. stocks bounced back from Thursday’s weakness on Friday, with the main indexes finishing firmer on Friday and for the week. Gilead drove the market early, announcing positive results from its Corona Virus vaccine clinical trial. Gains on Chinese stocks also helped to support the U.S. market.

Currencies ended the week as they started the week, trapped in tight ranges. Sterling did rise on the release of the latest U.K. stimulus plan. A weekend report from the Wall Street Journal noted that China and Iran are entering into a trade deal where China imports Iranian oil.

Oil prices again rose on Friday, supported by the Gilead news. Gold was weaker on the day.

Bias

Expect a very quiet start to the week, with markets still holding recent ranges and with no key data slated for today’s global session.

Trade the global markets with a broker that has integrity, honesty and transparency at its core

This website is owned and operated by the Ox Securities group of companies, which include:
Ox Securities Pty Ltd registered address Level 37, 1 Macquarie Place, Sydney NSW 2000 Australia. AFSL 438402 ACN 163 551 602
Ox Securities Limited (SV) registered address Suite 305, Griffith Corporate Centre, Beachmont, Kingstown, St Vincent and the Grenadines
Risk Warning: The information contained on this website is general in nature and does not constitute advice or a recommendation to act upon the information or an offer. The information on this website does not take into account your personal objectives, circumstances, financial situations or needs. You are strongly recommended to seek independent professional advice before opening an account with us and/or acquiring our services/products. Ox Securities Limited (SV) do not accept applications from residents of the United States of America and Australia
Before you decide whether or not to invest any products referred to on this website, being over the counter (OTC) derivatives, it is important for you to read and consider our Financial Services Guide (FSG), Product Disclosure Statement (PDS), and Terms and Conditions (T&C), and ensure that you fully understand the risks involved. Fees, charges and commissions apply. OTC derivatives, including margin foreign exchange contracts and contract for differences, are leveraged products that carry a high level of risk to your capital. Trading is not suitable for everyone. You may incur losses that are substantially greater than your initial investment. You do not own, or have any rights to, the underlying assets which the OTC derivative is referring to. You should only trade with money you can afford to lose. There are also risks associated with online trading including, but not limited to, hardware and/or software failures, and disruptions to communication systems and internet connectivity.

Copyright © OxSecurities 2020. All rights reserved